Cardiovascular Disease (CVD) Archives

AHA Names 7 Cardiovascular Research Breakthroughs in 2024

Expert

Prof. Rachel Giles

Conference

AHA 2024

19 December 2024 11:40

Discrepancy between cardiovascular RCT participants and real-life CKD patients could limit generalisability of RCT results

Presented By

Julia M.T. Colombijn, University Medical Centre Utrecht, the Netherlands

Conference

ERA 2024

Type

News article

20 June 2024 19:16

BRIDGE-TIMI 73a: Olezarsen halves triglyceride levels

Presented By

Dr Brian Bergmark, Brigham and Women's Hospital, USA

Trial

Phase 2, BRIDGE-TIMI 73a

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 14:41

High-risk and very high-risk patients meet LDL-cholesterol targets with lerodalcibep

Presented By

Prof. Eric Klug, University of the Witwatersrand, South Africa

Trial

Phase 3, LIBerate-HR

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 14:15

Anxiety and depression: Lifestyle influential in MACE prevention

Presented By

Dr Shady Abohashem, Massachusetts General Hospital, USA

Trial

Mass General Brigham Biobank

Conference

ACC 204

Type

Peer-reviewed article

16 May 2024 13:57

Successful results for semaglutide in the highly anticipated SELECT trial

Presented By

Dr Michael Lincoff, Cleveland Clinic, USA

Trial

Phase 3, SELECT

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:37

Cardiovascular disease and diabetes: new guidelines

Presented By

Prof. Emanuele Di Angelantonio; Prof. Nikolaus Marx; Dr Katharina Schuett; Prof. Dirk Müller-Wieland; Prof. Bianca Rocca

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:02

Key correlates of incident dementia identified in the MESA study

Presented By

Dr Mohammad Ostovaneh, Johns Hopkins Hospital, MD, USA

Trial

MESA

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:03

Olpasiran leads to dramatic reductions in Lp(a) concentrations

Presented By

Prof. Michelle O´Donoghue, Brigham and Women's Hospital, MA, USA

Trial

Phase 2, OCEAN(a)-DOSE

Conference

AHA 2023

Type

Peer-reviewed article

11 January 2023 12:50

Dietary supplements not effective in lowering LDL-C, use of low-dose statins encouraged

Presented By

Dr Luke Laffin, Cleveland Clinic, OH, USA

Trial

SPORT

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 12:45

Sotagliflozin SCORED MACE benefit

Presented By

Prof. Deepak Bhatt, Brigham and Women's Hospital, USA

Trial

Phase 3, SCORED

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 14:57

Plasma NfL levels associated with cardiovascular risk

Presented By

Dr Hugo Aparicio, Boston University School of Medicine, MA, USA

Conference

AAN 2022

Type

Peer-reviewed article

2 June 2022 16:47

Concomitant tricuspid annuloplasty reduces treatment failure in moderate tricuspid regurgitation

Presented By

Prof. James Gammie, University of Maryland, USA

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 16:46

COVID-19 mRNA vaccination benefits outweigh the risk for myocarditis

Presented By

Prof. Biykem Bozkurt, Baylor College of Medicine Houston, USA

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 16:24

Long-term reduced risk of CV events with ticagrelor plus aspirin after CABG

Presented By

Dr Qiang Zhao, Shanghai Jiao Tong University, China

Trial

DACAB-FE

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 16:17

Early surgery outperforms conservative management in asymptomatic severe aortic stenosis

Presented By

Prof. Marko Banovic, University Clinical Centre of Serbia, Serbia

Trial

AVATAR

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 16:11

External support device for SVG grafts in CABG surgery shows promise

Presented By

Prof. John Puskas, Mount Sinai Hospital, Israel

Trial

VEST Pivotal

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 16:04

Rivaroxaban regimen beneficial after revascularisation for claudication

Presented By

Prof. Marc Bonaca, University of Colorado, USA

Trial

VOYAGER PAD

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 15:57

LIBERTY 360 shows quality-of-life improvements after peripheral vascular intervention

Presented By

Dr Mohsin Chowdhury, Harvard Medical School, USA

Trial

LIBERTY 360

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 15:46

Deficient treatment outcomes after PVI in Black and low-income adults with PAD

Presented By

Dr Anna Krawisz, Beth Israel Deaconess Medical Center, MA, USA

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 15:39

REDUCE-IT: Cardiovascular risk reduction with icosapent ethyl in PAD

Presented By

Dr Deepak Bhatt, Brigham and Women’s Hospital, Boston, USA

Trial

Phase 3, REDUCE-IT

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 15:36

No significant effect of aspirin on reducing cognitive impairment

Presented By

Prof. Jane Armitage, Oxford University, UK

Trial

ASCEND

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 14:05

Network meta-analysis observes no clear effect of eicosapentaenoic acid on CV outcomes

Presented By

Dr Yujiro Yokoyama, St. Luke’s University Health Network, USA

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 13:31

2021 ESC Guidelines on Cardiovascular Disease Prevention

Presented By

Prof. Frank Visseren, Guidelines Task Force Chair

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 11:52

Echocardiographic parameters linked to dementia diagnosis

Presented By

Dr Karol Nowak, Jagiellonian University Medical College, Poland

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 12:49

No difference in ischaemic risk or bleeding with low vs high-dose aspirin for secondary prevention: Lessons and questions from the ADAPTABLE trial

Presented By

Prof. William Schuyler Jones , Duke Clinical Research Institute, USA

Trial

ADAPTABLE

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 23:03

AHA 2020: Polypill + aspirin prevents cardiovascular events

Presented By

Prof. Salim Yusuf , Population Health Research Institute, Hamilton, Canada

Trial

TIPS-3

Journal

Physician’s Weekly

Conference

AHA Scientific Sessions 2020

15 April 2021 16:38

AHA2020: Inclisiran effective across age and genders for hyperlipidemia

Presented By

Dr. Kausik “Kosh” Ray, Imperial College London, UK

Trial

Phase 3, ORION-11

Journal

Physician’s Weekly

Conference

AHA 2020

15 April 2021 16:23

No age cap for lipid-lowering therapy

Presented By

Prof. Børge Nordestgaard, University of Copenhagen, Denmark

Journal

Physician’s Weekly

Conference

AHA Scientific Sessions 2020

15 April 2021 15:28

Finerenone lowers CV events in diabetic CKD patients

Presented By

Prof. Gerasimos Filippatos, National and Kapodistrian University of Athens, Greece

Trial

Phase 3, FIDELIO-DKD

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:33

Intensive blood pressure lowering benefits older adults

Presented By

Prof. William Cushman, University of Tennessee Health Science, USA

Trial

SPRINT

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:13

Dapagliflozin reduces renal risk independent of CV disease status

Presented By

Prof. John McMurray, University of Glasgow, Scotland

Trial

DAPA-CKD

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 10:18

Clever trial design gets patients back on statins: the SAMSON trial

Presented By

Dr James Howard, Imperial College London, UK

Trial

SAMSON

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 15:10

Polypill plus aspirin reduces cardiovascular events

Presented By

Prof. Salim Yusuf, Population Health Research Institute, Canada

Trial

TIPS-3

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 14:58

Lowering LDL cholesterol in older patients is beneficial

Presented By

Dr Baris Gencer, Brigham and Women’s Hospital, USA

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 14:54

No CV benefit from omega 3 in high-risk patients

Presented By

Prof. Michael Lincoff, Cleveland Clinic, USA

Trial

STRENGTH

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 14:44

Safety and efficacy of inclisiran for hypercholesterolemia

Presented By

Prof. R. Scott Wright, Mayo Clinic, USA

Trial

Phase 3, ORION

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 14:37

Remote risk management programme effective and efficient

Presented By

Prof. Benjamin Scirica, Brigham and Women’s Hospital, USA

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 14:31

Healthy lifestyle lowers mortality irrespective of medication burden

Presented By

Dr Neil Kelly, Weill Cornell University, USA

Trial

REGARDS

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 14:24

Fewer CV complications than expected in AHA COVID-19 Registry

Presented By

Prof. James de Lemos, University of Texas Southwestern Medical Center, USA

Trial

AHA COVID-19 CVD Registry

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 13:39

Effects of CVD in hospitalised COVID-19 patients

Presented By

Prof. Ann Marie Navar, University of Texas Southwestern, USA

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 13:22

High-dose influenza vaccine in patients with CVD

Presented By

Prof. Orly Vardeny, University of Minnesota Medical School, USA

Trial

Phase 4, INVESTED

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 10:36

2020 Sports Cardiology and Exercise in Cardiovascular Patients Guidelines

Presented By

Prof. Antonio Pelliccia, Institute of Sports Medicine and Science, Italy

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:53

2020 Adult Congenital Heart Disease Guidelines

Presented By

Prof. Helmut Baumgartner, University Hospital Münster, Germany

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:46

SGLT2 inhibitor improves cardiovascular outcomes in heart failure patients

Presented By

Dr Milton Packer, Baylor University Medical Center, USA

Trial

Phase 3, EMPEROR-Reduced trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:40

Reduced cardiovascular outcomes with early rhythm control

Presented By

Prof. Paulus Kirchhof, University Heart & Vascular Center Hamburg, Germany

Trial

EAST-AFNET 4

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:35

DAPA-CKD: Dapagliflozin improves CKD survival ± diabetes

Presented By

Prof. Hiddo Heerspink, University of Groningen, the Netherlands

Trial

DAPA-CKD trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:23

Low-dose colchicine reduces CV death and ischaemic events in coronary disease

Presented By

Dr Stefan Nidorf, Heart Care Western Australia, Australia

Trial

LoDoCo2 trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:19

Antihypertensives also reduce CV risk in people with normal blood pressure

Presented By

Prof. Kazem Rahimi, University of Oxford, UK

Trial

BPLTTC study

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:14

Restrictive blood transfusion non-inferior and cost-effective strategy

Presented By

Prof. Philippe Gabriel Steg, University of Paris, Frane

Trial

REALITY trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:05

Increased mortality with colchicine in patients with ACS

Presented By

Prof. Jamie Layland , Monash University, Australia

Trial

COPS trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:00

Rivaroxaban protects limbs and ischaemic events in CAD-PAD patients

Presented By

Prof. William Hiatt, University of Colorado, USA

Trial

VOYAGER PAD trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 12:57

Antisense APOC3 oligonucleotide lowers triglyceride and atherogenic lipoproteins

Presented By

Prof. Jean-Claude Tardif, University of Montréal, Canada

Trial

Phase 2, AKCEA-APOCIII-LRx study

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 12:54

Reduced progression of coronary atherosclerosis with icosapent ethyl

Presented By

Prof. Matthew Budoff, Harbor-UCLA Medical Center, USA

Trial

EVAPORATE trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 12:48

SGLT2 inhibitor ertugliflozin shows similar mortality but fewer HF hospitalisations

Presented By

Prof. Francesco Cosentino, Karolinska University Hospital, Sweden

Trial

VERTIS CV

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 12:39

Risk factors for thromboembolism and bleeding in COVID-19: lessons from Wuhan

Presented By

Prof. Yutao Guo , Chinese PLA General Hospital, China

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 12:27

The Yale COVID-19 Cardiovascular Registry

Presented By

Dr Manan Pareek, Yale University School of Medicine, USA

Trial

Yale COVID-19 Cardiovascular Registry

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 12:24

Higher mortality risk with tramadol versus NSAIDs for osteoarthritis patients

Presented By

Lingyi Li, University of British Columbia, Canada

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 14:37

DAPA-HF: Dapagliflozin also good for heart failure patients without diabetes, of any age, or any health status

Presented By

Prof. John J. McMurray & Prof. Felipe A. Martinez

Trial

Phase 3, DAPA-HF

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 19:16

Complete revascularisation for obstructive non-culprit lesions with vulnerable plaque

Presented By

Dr Natalia Pinilla-Echeverri, McMaster University, Canada

Trial

COMPLETE

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 18:02

Phase 3 BETonMACE trial did not meet its primary endpoint

Presented By

Prof. Kausik K. Ray, Imperial College London, United Kingdom

Trial

Phase 3, BETonMACE

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 15:47

Inclisiran safely halves LDL-Cholesterol

Presented By

Prof. R. Scott Wright, Mayo Clinic, Rochester, USA

Trial

ORION-10

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 14:51

New guidelines on the prevention of cardiovascular conditions

Presented By

Prof. Roger S. Blumenthal, Johns Hopkins University, USA

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 14:36

Colchicine prevents cardiovascular events

Presented By

Prof. Jean-Claude Tardif, University of Montreal, Canada

Trial

COLCOT

Conference

AHA 2019

26 February 2020 13:56

Calcium pyrophosphate deposition disease: an independent risk factor for cardiovascular complications

Presented By

Dr Maaman Bashir, Medical College of Wisconsin, USA

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 22:45

CARDAS study shows increased prevalence of cardiac valvular disorders in AS patients

Presented By

Mr Milad Baniaamam, Amsterdam University Medical Center, the Netherlands

Trial

CARDAS

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 10:04

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 13:30

Landmark triple therapy trials

Presented By

Prof. Leonardo Fabbri, University of Modena and Reggio Emilia, Italy; Dr Konstantinos Kostikas, Novartis Pharma, Switzerland

Trial

Phase 3, IMPACT

Conference

ERS 2018

Type

Peer-reviewed article

7 November 2018 23:05